Compare Stocks

Date Range: 

 electroCoreElectromedSoleno TherapeuticsENDRA Life SciencesBioSig Technologies
SymbolNASDAQ:ECORNYSEAMERICAN:ELMDNASDAQ:SLNONASDAQ:NDRANASDAQ:BSGM
Price Information
Current Price$1.50$9.66$1.11$2.17$3.21
52 Week RangeBuyBuyBuyN/AN/A
MarketRank™
Overall Score1.42.01.90.60.5
Analysis Score3.53.53.50.00.0
Community Score2.12.32.82.32.7
Dividend Score0.00.00.00.00.0
Ownership Score0.80.82.50.00.0
Earnings & Valuation Score0.63.10.60.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/AN/A
Consensus Price Target$3.70$18.00$8.67N/AN/A
% Upside from Price Target146.67% upside86.34% upside680.78% upsideN/AN/A
Trade Information
Market Cap$72.81 million$83.41 million$88.49 million$90.36 million$103.18 million
Beta1.620.420.711.61.83
Average Volume3,263,72457,9921,586,2552,705,955312,433
Sales & Book Value
Annual Revenue$2.39 million$32.47 millionN/A$10,000.00N/A
Price / Sales30.472.57N/A9,035.88N/A
CashflowN/A$0.55 per shareN/AN/AN/A
Price / CashN/A17.49N/AN/AN/A
Book Value$0.84 per share$3.57 per share$0.33 per share$0.57 per share$0.53 per share
Price / Book1.792.71N/A3.81N/A
Profitability
Net Income$-45,150,000.00$4.16 million$-30,770,000.00$-13,310,000.00$-34,060,000.00
EPS($1.54)$0.47($0.70)($2.34)N/A
Trailing P/E RatioN/A23.00N/AN/A0.00
Forward P/E RatioN/A20.55N/AN/A
P/E GrowthN/A4.12N/AN/AN/A
Net Margins-792.01%11.44%N/AN/AN/A
Return on Equity (ROE)-109.15%12.39%-88.69%-492.76%-244.64%
Return on Assets (ROA)-79.64%11.15%-51.63%-288.58%-213.88%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.05%N/AN/A0.10%N/A
Current Ratio4.92%8.31%7.06%3.42%6.83%
Quick Ratio4.78%7.44%7.06%3.19%6.67%
Ownership Information
Institutional Ownership Percentage5.45%37.50%55.38%2.84%18.33%
Insider Ownership Percentage24.90%19.60%74.90%9.60%19.49%
Miscellaneous
Employees45120171849
Shares Outstanding48.54 million8.64 million79.72 million41.64 million32.14 million
Next Earnings Date8/12/2021 (Estimated)5/11/2021 (Confirmed)8/9/2021 (Estimated)5/17/2021 (Confirmed)5/10/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableNot Optionable
SourceHeadline
BioSig Technologies increases patient case goal to 1,500 procedures by end of 2021BioSig Technologies increases patient case goal to 1,500 procedures by end of 2021
proactiveinvestors.com - May 4 at 4:08 PM
BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing SystemBioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System
finance.yahoo.com - May 4 at 11:07 AM
Will BioSig Technologies (NASDAQ:BSGM) Spend Its Cash Wisely?Will BioSig Technologies (NASDAQ:BSGM) Spend Its Cash Wisely?
nasdaq.com - May 3 at 12:48 PM
BioSig Technologies, Inc. Invited to Present at Wall Street ConferenceBioSig Technologies, Inc. Invited to Present at Wall Street Conference
finance.yahoo.com - May 3 at 12:48 PM
Is BioSig Technologies, Inc.s (NASDAQ:BSGM) Shareholder Ownership Skewed Towards Insiders?Is BioSig Technologies, Inc.'s (NASDAQ:BSGM) Shareholder Ownership Skewed Towards Insiders?
finance.yahoo.com - May 3 at 7:47 AM
BioSig says physicians at Mayo Clinic’s campus in Phoenix, Arizona...BioSig says physicians at Mayo Clinic’s campus in Phoenix, Arizona...
proactiveinvestors.com - April 29 at 7:15 PM
Biosig Technologies Inc (BSGM)Biosig Technologies Inc (BSGM)
investing.com - April 29 at 7:15 PM
Head-To-Head Comparison: Star Equity (NASDAQ:STRR) vs. BioSig Technologies (NASDAQ:BSGM)Head-To-Head Comparison: Star Equity (NASDAQ:STRR) vs. BioSig Technologies (NASDAQ:BSGM)
americanbankingnews.com - April 28 at 10:38 AM
Exclusive: BioSigs Cardiac Signal Processing System Now Used At Mayo Clinics Phoenix CampusExclusive: BioSig's Cardiac Signal Processing System Now Used At Mayo Clinic's Phoenix Campus
msn.com - April 27 at 3:36 PM
BioSigs Cardiac Signal Processing System Now Used At Mayo Clinics Phoenix CampusBioSig's Cardiac Signal Processing System Now Used At Mayo Clinic's Phoenix Campus
msn.com - April 27 at 10:36 AM
BioSig’s PURE EP(tm) System Evaluated with Patients at Mayo Clinic in ArizonaBioSig’s PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona
finance.yahoo.com - April 27 at 10:36 AM
BioSig gaining momentum with proprietary AFib-treating techBioSig gaining momentum with proprietary AFib-treating tech
westfaironline.com - April 19 at 8:12 AM
BioSig Expands Commercial Team in Two Strategic RegionsBioSig Expands Commercial Team in Two Strategic Regions
finance.yahoo.com - April 15 at 12:57 PM
BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis ...BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis ...
apnews.com - April 14 at 3:46 PM
BioSig Technologies announces release of the PURE EP Software Version 4BioSig Technologies announces release of the PURE EP Software Version 4
proactiveinvestors.com - April 14 at 3:46 PM
BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology PlatformBioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology Platform
finance.yahoo.com - April 14 at 10:43 AM
BioSig Technologies completes enrollment in its PURE EP 2.0 clinical trialBioSig Technologies completes enrollment in its PURE EP 2.0 clinical trial
proactiveinvestors.com - April 13 at 6:45 PM
BioSig Technologies completes enrollment in PURE EP 2.0 clinical trialBioSig Technologies completes enrollment in PURE EP 2.0 clinical trial
proactiveinvestors.com - April 13 at 1:44 PM
BioSig Completes Enrollment in the PURE EP 2.0 Clinical StudyBioSig Completes Enrollment in the PURE EP 2.0 Clinical Study
finance.yahoo.com - April 13 at 1:44 PM
BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH)BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH)
finance.yahoo.com - April 9 at 2:26 PM
BioSig Technologies says top-rated leading hospital system has purchased its PURE EP systems for multiple campuses in its national networkBioSig Technologies says top-rated leading hospital system has purchased its PURE EP systems for multiple campuses in its national network
proactiveinvestors.com - April 6 at 1:22 PM
BioSig Awarded U.S. Patent Claims for the Noise-Filtering Methods for its Signal Processing ...BioSig Awarded U.S. Patent Claims for the Noise-Filtering Methods for its Signal Processing ...
apnews.com - March 31 at 3:20 AM
BioSig Technologies awarded US patent claims for noise-filtering methods of signal processing technologyBioSig Technologies awarded US patent claims for noise-filtering methods of signal processing technology
proactiveinvestors.com - March 30 at 12:19 PM
BioSig Issues Shareholder Letter with Corporate Update on Recent Achievements and Anticipated ...BioSig Issues Shareholder Letter with Corporate Update on Recent Achievements and Anticipated ...
apnews.com - March 30 at 7:18 AM
BioSig CEO says PURE EP System is “gaining momentum” as it adds new healthcare facilitiesBioSig CEO says PURE EP System is “gaining momentum” as it adds new healthcare facilities
proactiveinvestors.com - March 29 at 8:58 PM
DateCompanyBrokerageAction
3/12/2021electroCoreMaxim GroupReiterated Rating
10/23/2020electroCoreBrookline Capital ManagementInitiated Coverage
8/14/2020electroCoreHC WainwrightBoost Price Target
8/14/2020electroCoreBTIG ResearchUpgrade
5/19/2020electroCoreNoble FinancialReiterated Rating
3/24/2020electroCoreCantor FitzgeraldLower Price Target
11/14/2019electroCoreJMP SecuritiesDowngrade
11/13/2019electroCoreEvercore ISIReiterated Rating
3/25/2021ElectromedNorthland SecuritiesReiterated Rating
3/8/2021ElectromedColliers SecuritiesReiterated Rating
11/1/2019ElectromedDougherty & CoReiterated Rating
3/3/2021Soleno TherapeuticsOppenheimerReiterated Rating
9/29/2020Soleno TherapeuticsGuggenheimInitiated Coverage
6/5/2020Soleno TherapeuticsLaidlawReiterated Rating
1/10/2020Soleno TherapeuticsCraig HallumInitiated Coverage
6/22/2018Soleno TherapeuticsRoth CapitalInitiated Coverage
5/20/2019ENDRA Life SciencesLake Street CapitalInitiated Coverage
(Data available from 5/9/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.